Evaluation of the Efficacy and Safety of Anti-angiogenic Therapy With Intravenous Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations

Conditions: Cerebral AV Malformation Interventions: Drug: Bevacizumab; Drug: Placebo Sponsors: Fondation Ophtalmologique Adolphe de Rothschild Not yet recruiting

Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials